APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Pharmaceuticals

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pet Pharmaceuticals Market Outlook and Growth Opportunities 2026

29 December 2025198 pages

Choose your research edition.

Industry ResearchPet Pharmaceuticals Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Pharmaceuticals Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Pet Pharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Pharmaceuticals Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Pharmaceuticals Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Pet Pharmaceuticals market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pet Pharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pet Pharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Pharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pet Pharmaceuticals market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pet Pharmaceuticals market include CAHIC, Chopperlvya Animal Health, Merck, Jindun, Zoetis, Virbac, Vetoquinol, Ouro Fino Saude and Norbrook, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pet Pharmaceuticals market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pet Pharmaceuticals and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pet Pharmaceuticals sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pet Pharmaceuticals market size, projected growth trends, production technologies, key applications, and end-use industries.

Pet Pharmaceuticals Segment by Company

CAHIC

Chopperlvya Animal Health

Merck

Jindun

Zoetis

Virbac

Vetoquinol

Ouro Fino Saude

Norbrook

Elanco

Dechra Veterinary Products

Ceva

Boehringer Ingelheim

Pet Pharmaceuticals Segment by Type

Antiparasitic

Antibacterial

Biological Products

Others

Pet Pharmaceuticals Segment by Application

Prevention

Treatment

Pet Pharmaceuticals Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Pet Pharmaceuticals status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pet Pharmaceuticals market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pet Pharmaceuticals significant trends, drivers, influence factors in global and regions.

6. To analyze Pet Pharmaceuticals competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Pharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Pharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Pharmaceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pet Pharmaceuticals market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pet Pharmaceuticals industry.

Chapter 3: Detailed analysis of Pet Pharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pet Pharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pet Pharmaceuticals in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pet Pharmaceuticals Industry Trends Table 2. Pet Pharmaceuticals Industry Drivers Table 3. Pet Pharmaceuticals Industry Opportunities and Challenges Table 4. Pet Pharmaceuticals Industry Restraints Table 5. Global Pet Pharmaceuticals Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pet Pharmaceuticals Revenue Share by Company (2021-2026) Table 7. Global Pet Pharmaceuticals Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Pet Pharmaceuticals Sales Volume Share by Company (2021-2026) Table 9. Global Pet Pharmaceuticals Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Pet Pharmaceuticals Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pet Pharmaceuticals Key Company Manufacturing Base & Headquarters Table 12. Global Pet Pharmaceuticals Company, Product Type & Application Table 13. Global Pet Pharmaceuticals Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pet Pharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Antiparasitic Table 18. Significant Companies of Antibacterial Table 19. Significant Companies of Biological Products Table 20. Significant Companies of Others Table 21. Global Pet Pharmaceuticals Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Pet Pharmaceuticals Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Pet Pharmaceuticals Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Pet Pharmaceuticals Sales Volume Share by Type (2021-2026) Table 25. Global Pet Pharmaceuticals Sales Volume Share by Type (2027-2032) Table 26. Global Pet Pharmaceuticals Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pet Pharmaceuticals Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Pet Pharmaceuticals Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Pet Pharmaceuticals Sales Value Share by Type (2021-2026) Table 30. Global Pet Pharmaceuticals Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Prevention Table 32. Significant Companies of Treatment Table 33. Global Pet Pharmaceuticals Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Pet Pharmaceuticals Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Pet Pharmaceuticals Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Pet Pharmaceuticals Sales Volume Share by Application (2021-2026) Table 37. Global Pet Pharmaceuticals Sales Volume Share by Application (2027-2032) Table 38. Global Pet Pharmaceuticals Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Pet Pharmaceuticals Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Pet Pharmaceuticals Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Pet Pharmaceuticals Sales Value Share by Application (2021-2026) Table 42. Global Pet Pharmaceuticals Sales Value Share by Application (2027-2032) Table 43. Global Pet Pharmaceuticals Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Pet Pharmaceuticals Sales by Region (2021-2026) & (K Units) Table 45. Global Pet Pharmaceuticals Sales Market Share by Region (2021-2026) Table 46. Global Pet Pharmaceuticals Sales by Region (2027-2032) & (K Units) Table 47. Global Pet Pharmaceuticals Sales Market Share by Region (2027-2032) Table 48. Global Pet Pharmaceuticals Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Pet Pharmaceuticals Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Pet Pharmaceuticals Sales Value Share by Region (2021-2026) Table 51. Global Pet Pharmaceuticals Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Pet Pharmaceuticals Sales Value Share by Region (2027-2032) Table 53. Global Pet Pharmaceuticals Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Pet Pharmaceuticals Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Pet Pharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Pet Pharmaceuticals Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Pet Pharmaceuticals Sales by Country (2021-2026) & (K Units) Table 58. Global Pet Pharmaceuticals Sales Market Share by Country (2021-2026) Table 59. Global Pet Pharmaceuticals Sales by Country (2027-2032) & (K Units) Table 60. Global Pet Pharmaceuticals Sales Market Share by Country (2027-2032) Table 61. Global Pet Pharmaceuticals Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Pet Pharmaceuticals Sales Value Market Share by Country (2021-2026) Table 63. Global Pet Pharmaceuticals Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Pet Pharmaceuticals Sales Value Market Share by Country (2027-2032) Table 65. CAHIC Company Information Table 66. CAHIC Business Overview Table 67. CAHIC Pet Pharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. CAHIC Pet Pharmaceuticals Product Portfolio Table 69. CAHIC Recent Development Table 70. Chopperlvya Animal Health Company Information Table 71. Chopperlvya Animal Health Business Overview Table 72. Chopperlvya Animal Health Pet Pharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Chopperlvya Animal Health Pet Pharmaceuticals Product Portfolio Table 74. Chopperlvya Animal Health Recent Development Table 75. Merck Company Information Table 76. Merck Business Overview Table 77. Merck Pet Pharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Merck Pet Pharmaceuticals Product Portfolio Table 79. Merck Recent Development Table 80. Jindun Company Information Table 81. Jindun Business Overview Table 82. Jindun Pet Pharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Jindun Pet Pharmaceuticals Product Portfolio Table 84. Jindun Recent Development Table 85. Zoetis Company Information Table 86. Zoetis Business Overview Table 87. Zoetis Pet Pharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Zoetis Pet Pharmaceuticals Product Portfolio Table 89. Zoetis Recent Development Table 90. Virbac Company Information Table 91. Virbac Business Overview Table 92. Virbac Pet Pharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Virbac Pet Pharmaceuticals Product Portfolio Table 94. Virbac Recent Development Table 95. Vetoquinol Company Information Table 96. Vetoquinol Business Overview Table 97. Vetoquinol Pet Pharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Vetoquinol Pet Pharmaceuticals Product Portfolio Table 99. Vetoquinol Recent Development Table 100. Ouro Fino Saude Company Information Table 101. Ouro Fino Saude Business Overview Table 102. Ouro Fino Saude Pet Pharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Ouro Fino Saude Pet Pharmaceuticals Product Portfolio Table 104. Ouro Fino Saude Recent Development Table 105. Norbrook Company Information Table 106. Norbrook Business Overview Table 107. Norbrook Pet Pharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Norbrook Pet Pharmaceuticals Product Portfolio Table 109. Norbrook Recent Development Table 110. Elanco Company Information Table 111. Elanco Business Overview Table 112. Elanco Pet Pharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Elanco Pet Pharmaceuticals Product Portfolio Table 114. Elanco Recent Development Table 115. Dechra Veterinary Products Company Information Table 116. Dechra Veterinary Products Business Overview Table 117. Dechra Veterinary Products Pet Pharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Dechra Veterinary Products Pet Pharmaceuticals Product Portfolio Table 119. Dechra Veterinary Products Recent Development Table 120. Ceva Company Information Table 121. Ceva Business Overview Table 122. Ceva Pet Pharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Ceva Pet Pharmaceuticals Product Portfolio Table 124. Ceva Recent Development Table 125. Boehringer Ingelheim Company Information Table 126. Boehringer Ingelheim Business Overview Table 127. Boehringer Ingelheim Pet Pharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Boehringer Ingelheim Pet Pharmaceuticals Product Portfolio Table 129. Boehringer Ingelheim Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Pet Pharmaceuticals Distributors List Table 133. Pet Pharmaceuticals Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Pet Pharmaceuticals Product Image Figure 2. Global Pet Pharmaceuticals Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Pharmaceuticals Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pet Pharmaceuticals Sales (2021-2032) & (K Units) Figure 5. Global Pet Pharmaceuticals Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Pet Pharmaceuticals Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Antiparasitic Image Figure 10. Antibacterial Image Figure 11. Biological Products Image Figure 12. Others Image Figure 13. Global Pet Pharmaceuticals Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Pet Pharmaceuticals Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Pet Pharmaceuticals Sales Volume Share by Type (2021-2032) Figure 16. Global Pet Pharmaceuticals Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pet Pharmaceuticals Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Pet Pharmaceuticals Sales Value Share by Type (2021-2032) Figure 19. Prevention Image Figure 20. Treatment Image Figure 21. Global Pet Pharmaceuticals Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Pet Pharmaceuticals Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Pet Pharmaceuticals Sales Volume Share by Application (2021-2032) Figure 24. Global Pet Pharmaceuticals Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Pet Pharmaceuticals Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Pet Pharmaceuticals Sales Value Share by Application (2021-2032) Figure 27. Global Pet Pharmaceuticals Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Pet Pharmaceuticals Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Pet Pharmaceuticals Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Pet Pharmaceuticals Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Pet Pharmaceuticals Sales Value (2021-2032) & (US$ Million) Figure 32. North America Pet Pharmaceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Pet Pharmaceuticals Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Pet Pharmaceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Pet Pharmaceuticals Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Pet Pharmaceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Pet Pharmaceuticals Sales Value (2021-2032) & (US$ Million) Figure 38. South America Pet Pharmaceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Pet Pharmaceuticals Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Pet Pharmaceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Pet Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Pet Pharmaceuticals Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Pet Pharmaceuticals Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Antiparasitic
  • Antibacterial
  • Biological Products
  • Others
Applications
  • Prevention
  • Treatment
Companies covered
  • CAHIC
  • Chopperlvya Animal Health
  • Merck
  • Jindun
  • Zoetis
  • Virbac
  • Vetoquinol
  • Ouro Fino Saude
  • Norbrook
  • Elanco
  • Dechra Veterinary Products
  • Ceva
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pet Pharmaceuticals Sales Value (2021-2032)
  4. 1.2.2 Global Pet Pharmaceuticals Sales Volume (2021-2032)
  5. 1.2.3 Global Pet Pharmaceuticals Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pet Pharmaceuticals Market Dynamics
  1. 2.1 Pet Pharmaceuticals Industry Trends
  2. 2.2 Pet Pharmaceuticals Industry Drivers
  3. 2.3 Pet Pharmaceuticals Industry Opportunities and Challenges
  4. 2.4 Pet Pharmaceuticals Industry Restraints
3 Pet Pharmaceuticals Market by Company
  1. 3.1 Global Pet Pharmaceuticals Company Revenue Ranking in 2025
  2. 3.2 Global Pet Pharmaceuticals Revenue by Company (2021-2026)
  3. 3.3 Global Pet Pharmaceuticals Sales Volume by Company (2021-2026)
  4. 3.4 Global Pet Pharmaceuticals Average Price by Company (2021-2026)
  5. 3.5 Global Pet Pharmaceuticals Company Ranking (2024-2026)
  6. 3.6 Global Pet Pharmaceuticals Company Manufacturing Base and Headquarters
  7. 3.7 Global Pet Pharmaceuticals Company Product Type and Application
  8. 3.8 Global Pet Pharmaceuticals Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pet Pharmaceuticals Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pet Pharmaceuticals Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pet Pharmaceuticals Market by Type
  1. 4.1 Pet Pharmaceuticals Type Introduction
  2. 4.1.1 Antiparasitic
  3. 4.1.2 Antibacterial
  4. 4.1.3 Biological Products
  5. 4.1.4 Others
  6. 4.2 Global Pet Pharmaceuticals Sales Volume by Type
  7. 4.2.1 Global Pet Pharmaceuticals Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pet Pharmaceuticals Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Pet Pharmaceuticals Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Pet Pharmaceuticals Sales Value by Type
  11. 4.3.1 Global Pet Pharmaceuticals Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Pet Pharmaceuticals Sales Value by Type (2021-2032)
  13. 4.3.3 Global Pet Pharmaceuticals Sales Value Share by Type (2021-2032)
5 Pet Pharmaceuticals Market by Application
  1. 5.1 Pet Pharmaceuticals Application Introduction
  2. 5.1.1 Prevention
  3. 5.1.2 Treatment
  4. 5.2 Global Pet Pharmaceuticals Sales Volume by Application
  5. 5.2.1 Global Pet Pharmaceuticals Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pet Pharmaceuticals Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Pet Pharmaceuticals Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Pet Pharmaceuticals Sales Value by Application
  9. 5.3.1 Global Pet Pharmaceuticals Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Pet Pharmaceuticals Sales Value by Application (2021-2032)
  11. 5.3.3 Global Pet Pharmaceuticals Sales Value Share by Application (2021-2032)
6 Pet Pharmaceuticals Regional Sales and Value Analysis
  1. 6.1 Global Pet Pharmaceuticals Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pet Pharmaceuticals Sales by Region (2021-2032)
  3. 6.2.1 Global Pet Pharmaceuticals Sales by Region: 2021-2026
  4. 6.2.2 Global Pet Pharmaceuticals Sales by Region (2027-2032)
  5. 6.3 Global Pet Pharmaceuticals Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pet Pharmaceuticals Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pet Pharmaceuticals Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pet Pharmaceuticals Sales Value by Region (2027-2032)
  9. 6.5 Global Pet Pharmaceuticals Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pet Pharmaceuticals Sales Value (2021-2032)
  12. 6.6.2 North America Pet Pharmaceuticals Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pet Pharmaceuticals Sales Value (2021-2032)
  15. 6.7.2 Europe Pet Pharmaceuticals Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pet Pharmaceuticals Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pet Pharmaceuticals Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pet Pharmaceuticals Sales Value (2021-2032)
  21. 6.9.2 South America Pet Pharmaceuticals Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pet Pharmaceuticals Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pet Pharmaceuticals Sales Value Share by Country, 2025 VS 2032
7 Pet Pharmaceuticals Country-level Sales and Value Analysis
  1. 7.1 Global Pet Pharmaceuticals Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pet Pharmaceuticals Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pet Pharmaceuticals Sales by Country (2021-2032)
  4. 7.3.1 Global Pet Pharmaceuticals Sales by Country (2021-2026)
  5. 7.3.2 Global Pet Pharmaceuticals Sales by Country (2027-2032)
  6. 7.4 Global Pet Pharmaceuticals Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pet Pharmaceuticals Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pet Pharmaceuticals Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pet Pharmaceuticals Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pet Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pet Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CAHIC
  2. 8.1.1 CAHIC Company Information
  3. 8.1.2 CAHIC Business Overview
  4. 8.1.3 CAHIC Pet Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CAHIC Pet Pharmaceuticals Product Portfolio
  6. 8.1.5 CAHIC Recent Developments
  7. 8.2 Chopperlvya Animal Health
  8. 8.2.1 Chopperlvya Animal Health Company Information
  9. 8.2.2 Chopperlvya Animal Health Business Overview
  10. 8.2.3 Chopperlvya Animal Health Pet Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Chopperlvya Animal Health Pet Pharmaceuticals Product Portfolio
  12. 8.2.5 Chopperlvya Animal Health Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Pet Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck Pet Pharmaceuticals Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Jindun
  20. 8.4.1 Jindun Company Information
  21. 8.4.2 Jindun Business Overview
  22. 8.4.3 Jindun Pet Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Jindun Pet Pharmaceuticals Product Portfolio
  24. 8.4.5 Jindun Recent Developments
  25. 8.5 Zoetis
  26. 8.5.1 Zoetis Company Information
  27. 8.5.2 Zoetis Business Overview
  28. 8.5.3 Zoetis Pet Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Zoetis Pet Pharmaceuticals Product Portfolio
  30. 8.5.5 Zoetis Recent Developments
  31. 8.6 Virbac
  32. 8.6.1 Virbac Company Information
  33. 8.6.2 Virbac Business Overview
  34. 8.6.3 Virbac Pet Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Virbac Pet Pharmaceuticals Product Portfolio
  36. 8.6.5 Virbac Recent Developments
  37. 8.7 Vetoquinol
  38. 8.7.1 Vetoquinol Company Information
  39. 8.7.2 Vetoquinol Business Overview
  40. 8.7.3 Vetoquinol Pet Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Vetoquinol Pet Pharmaceuticals Product Portfolio
  42. 8.7.5 Vetoquinol Recent Developments
  43. 8.8 Ouro Fino Saude
  44. 8.8.1 Ouro Fino Saude Company Information
  45. 8.8.2 Ouro Fino Saude Business Overview
  46. 8.8.3 Ouro Fino Saude Pet Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Ouro Fino Saude Pet Pharmaceuticals Product Portfolio
  48. 8.8.5 Ouro Fino Saude Recent Developments
  49. 8.9 Norbrook
  50. 8.9.1 Norbrook Company Information
  51. 8.9.2 Norbrook Business Overview
  52. 8.9.3 Norbrook Pet Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Norbrook Pet Pharmaceuticals Product Portfolio
  54. 8.9.5 Norbrook Recent Developments
  55. 8.10 Elanco
  56. 8.10.1 Elanco Company Information
  57. 8.10.2 Elanco Business Overview
  58. 8.10.3 Elanco Pet Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Elanco Pet Pharmaceuticals Product Portfolio
  60. 8.10.5 Elanco Recent Developments
  61. 8.11 Dechra Veterinary Products
  62. 8.11.1 Dechra Veterinary Products Company Information
  63. 8.11.2 Dechra Veterinary Products Business Overview
  64. 8.11.3 Dechra Veterinary Products Pet Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Dechra Veterinary Products Pet Pharmaceuticals Product Portfolio
  66. 8.11.5 Dechra Veterinary Products Recent Developments
  67. 8.12 Ceva
  68. 8.12.1 Ceva Company Information
  69. 8.12.2 Ceva Business Overview
  70. 8.12.3 Ceva Pet Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Ceva Pet Pharmaceuticals Product Portfolio
  72. 8.12.5 Ceva Recent Developments
  73. 8.13 Boehringer Ingelheim
  74. 8.13.1 Boehringer Ingelheim Company Information
  75. 8.13.2 Boehringer Ingelheim Business Overview
  76. 8.13.3 Boehringer Ingelheim Pet Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Boehringer Ingelheim Pet Pharmaceuticals Product Portfolio
  78. 8.13.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pet Pharmaceuticals Value Chain Analysis
  2. 9.1.1 Pet Pharmaceuticals Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pet Pharmaceuticals Sales Mode & Process
  6. 9.2 Pet Pharmaceuticals Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pet Pharmaceuticals Distributors
  9. 9.2.3 Pet Pharmaceuticals Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst